Skip to main content

Involvement of microRNA-718, a new regulator of EGR3, in regulation of malignant phenotype of HCC cells

miR-718 和EGR3 参与调控肝癌细胞系的恶性表型的研究

Journal of Zhejiang University-SCIENCE B volume 18, pages 27–36 (2017)Cite this article

Abstract

Objective

Hepatocellular carcinoma (HCC) is still one of the most common death-related malignancies worldwide. Because the way onset and progression are hidden most, HCC diagnoses are made at an advanced stage, when they are unsuitable for surgical resection. MicroRNAs are a class of small non-coding RNAs, participating in many aspects of cancers. In this study, we tried to establish the role of microRNA-718 (miR-718) in the malignant phenotype of HCC cells and its possible role in HCC diagnosis.

Methods

Here we first used a methylthiazolyldiphenyl-tetrazolium bromide (MTT) assay, Transwell migration and invasion assays, and colony formation assay to evaluate the impact of miR-718 on the malignant phenotypes of HCC cells. Then, we used bioinformatic methods to predict the target gene of miR-718 and used green fluorescence protein (GFP) reporter assay, Western blot, and quantitative real-time polymerase chain reaction (qRT-PCR) to validate the regulation relationship. Finally, we determined the role of the target gene in the HCC phenotype.

Results

We found that the expression of miR-718 was significantly reduced in various HCC cell lines and HCC tissues. Re-expression of miR-718 significantly reduced the cellular viability and colony formation ability as well as inhibited the migration and invasion abilities of HCC cell lines. Early growth response protein 3 (EGR3) is a direct target of miR-718 and is negatively regulated by miR-718. EGR3 could increase the viability and proliferation of HCC cells, and promot the migration and invasion of HCC cells.

Conclusions

miR-718 acts as a tumor suppressive microRNA in HCC via regulating the expression of EGR3, which may provide a new diagnostic marker and treatment target for HCC.

概要

目 的

研究miR-718 和早期生长反应蛋白3(EGR3)在肝癌细胞系HepG2 及SMMC-7721 中对细胞恶性行为的作用。

创新点

首次在肝癌细胞系HepG2 和SMMC-7721 中发现miR-718 作为抑癌基因及EGR3 作为促癌基因起到调控肿瘤恶性行为的作用。

方 法

采用聚合酶链反应(PCR)方法构建miR-718 和EGR3 的过表达及敲降质粒, 并采用实时定量PCR(qRT-PCR)方法验证质粒有效性; 采用MTT 法和克隆形成实验检测肝癌细胞系HepG2和SMMC-7721 的生长增殖能力; 采用Transwell迁移侵袭实验检测肝癌细胞系HepG2 和SMMC-7721 的迁移和侵袭能力; 采用增强型绿色荧光蛋白(EGFP)荧光报告载体实验验证miR-718 的靶基因; 采用qRT-PCR 和蛋白质印迹(Western blot)检测相关基因表达水平的变化。

结 论

miR-718 在肝癌细胞系HepG2 和SMMC-7721 中起到抑癌基因的作用; EGR3 在肝癌细胞系HepG2 和SMMC-7721 中起到促癌基因的作用; miR-718 是通过靶定EGR3 mRNA 3' UTR 下调EGR3 的表达起到抑癌基因的作用。

This is a preview of subscription content, access via your institution.

Access options

Buy single article

Instant access to the full article PDF.

43,34 €

Price includes VAT (Finland)
Tax calculation will be finalised during checkout.

References

  • Ameres, S.L., Zamore, P.D., 2013. Diversifying microRNA sequence and function. Nat. Rev. Mol. Cell Biol., 14(8):475–488. http://dx.doi.org/10.1038/nrm3611

    CAS  Article  PubMed  Google Scholar 

  • Baron, V.T., Pio, R., Jia, Z., et al., 2015. Early growth response 3 regulates genes of inflammation and directly activates IL6 and IL8 expression in prostate cancer. Br. J. Cancer, 112(4):755–764. http://dx.doi.org/10.1038/bjc.2014.622

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  • Bartel, D.P., 2009. MicroRNAs: target recognition and regulatory functions. Cell, 136(2):215–233. http://dx.doi.org/10.1016/j.cell.2009.01.002

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  • Bronte, F., Bronte, G., Fanale, D., et al., 2015. Hepatomirnoma:the proposal of a new network of targets for diagnosis, prognosis and therapy in hepatocellular carcinoma. Crit. Rev. Oncol. Hematol., 97:312–321. http://dx.doi.org/10.1016/j.critrevonc.2015.09.007

    Article  PubMed  Google Scholar 

  • Fang, F., Shangguan, A.J., Kelly, K., et al., 2013. Early growth response 3 (Egr-3) is induced by transforming growth factor-β and regulates fibrogenic responses. Am. J. Pathol., 183(4):1197–1208. http://dx.doi.org/10.1016/j.ajpath.2013.06.016

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  • Farazi, T.A., Juranek, S.A., Tuschl, T., 2008. The growing catalog of small RNAs and their association with distinct Argonaute/Piwi family members. Development, 135(7):1201–1214. http://dx.doi.org/10.1242/dev.005629

    CAS  Article  PubMed  Google Scholar 

  • Felekkis, K., Touvana, E., Stefanou, C., et al., 2010. MicroRNAs: a newly described class of encoded molecules that play a role in health and disease. Hippokratia, 14(4):236–240.

    CAS  PubMed  PubMed Central  Google Scholar 

  • Fong, Z.V., Tanabe, K.K., 2014. The clinical management of hepatocellular carcinoma in the United States, Europe, and Asia: a comprehensive and evidence-based comparison and review. Cancer, 120(18):2824–2838. http://dx.doi.org/10.1002/cncr.28730

    Article  PubMed  Google Scholar 

  • Gomez-Martin, D., Diaz-Zamudio, M., Galindo-Campos, M., et al., 2010. Early growth response transcription factors and the modulation of immune response: implications towards autoimmunity. Autoimmun. Rev., 9(6):454–458. http://dx.doi.org/10.1016/j.autrev.2009.12.006

    CAS  Article  PubMed  Google Scholar 

  • Hu, X., Schwarz, J.K., Lewis, J.S., et al., 2010. A microRNA expression signature for cervical cancer prognosi, Cancer Res., 70(4):1441–1448. http://dx.doi.org/10.1158/0008-5472.can-09-3289

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  • Kimhofer, T., Fye, H., Taylor-Robinson, S., et al., 2015. Proteomic and metabonomic biomarkers for hepatocellular carcinoma: a comprehensive review. Br. J. Cancer, 112(7):1141–1156. http://dx.doi.org/10.1038/bjc.2015.38

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  • Leng, R., Zha, L., Tang, L., 2014. MiR-718 represses VEGF and inhibits ovarian cancer cell progression. FEBS Lett., 588(12):2078–2086. http://dx.doi.org/10.1016/j.febslet.2014.04.040

    CAS  Article  PubMed  Google Scholar 

  • Li, L., Yun, S.H., Keblesh, J., et al., 2007. Egr3, a synaptic activity regulated transcription factor that is essential for learning and memory. Mol. Cell. Neurosci., 35(1):76–88. http://dx.doi.org/10.1016/j.mcn.2007.02.004

    Article  PubMed  PubMed Central  Google Scholar 

  • Liao, F., Ji, M.Y., Shen, L., et al., 2013. Decreased Egr3 expression is related to poor prognosis in patients with gastric cancer. J. Mol. Histol., 44(4):463–468. http://dx.doi.org/10.1007/s10735-013-9493-8

    CAS  Article  PubMed  Google Scholar 

  • Lin, M., Chen, W., Huang, J., et al., 2011. MicroRNA expression profiles in human colorectal cancers with liver metastases. Oncol. Rep., 25(3):739–747. http://dx.doi.org/10.3892/or.2010.1112

    CAS  Article  PubMed  Google Scholar 

  • Perez-Cadahia, B., Drobic, B., Davie, J.R., 2011. Activation and function of immediate-early genes in the nervous system. Biochem. Cell Biol., 89(1):61–73. http://dx.doi.org/10.1139/o10-138

    CAS  Article  PubMed  Google Scholar 

  • Pio, R., Jia, Z., Baron, V.T., et al., 2013. Early growth response 3 (Egr3) is highly over-expressed in nonrelapsing prostate cancer but not in relapsing prostate cancer. PLoS ONE, 8(1):e54096. http://dx.doi.org/10.1371/journal.pone.0054096

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  • Shukla, G.C., Singh, J., Barik, S., 2011. MicroRNAs: processing, maturation, target recognition and regulatory functions. Mol. Cell. Pharmacol., 3(3):83–92.

    CAS  PubMed  PubMed Central  Google Scholar 

  • Singh, R., Yadav, V., Kumar, S., et al., 2015. MicroRNA-195 inhibits proliferation, invasion and metastasis in breast cancer cells by targeting FASN, HMGCR, ACACA and CYP27B1. Sci. Rep., 5:17454. http://dx.doi.org/10.1038/srep17454

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  • Sugimachi, K., Matsumura, T., Hirata, H., et al., 2015. Identification of a bona fide microRNA biomarker in serum exosomes that predicts hepatocellular carcinoma recurrence after liver transplantation. Br. J. Cancer, 112(3):532–538. http://dx.doi.org/10.1038/bjc.2014.621

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  • Suzuki, T., Inoue, A., Miki, Y., et al., 2007. Early growth responsive gene 3 in human breast carcinoma: a regulator of estrogen-meditated invasion and a potent prognostic factor. Endocr. Relat. Cancer, 14(2):279–292. http://dx.doi.org/10.1677/erc-06-0005

    CAS  Article  PubMed  Google Scholar 

  • Waller, L.P., Deshpande, V., Pyrsopoulos, N., 2015. Hepatocellular carcinoma: a comprehensive review. World J. Hepatol., 7(26):2648–2663. http://dx.doi.org/10.4254/wjh.v7.i26.2648

    Article  PubMed  PubMed Central  Google Scholar 

  • Wan, H.Y., Li, Q.Q., Zhang, Y., et al., 2014. MiR-124 represses vasculogenic mimicry and cell motility by targeting amotL1 in cervical cancer cells. Cancer Lett., 355(1):148–158. http://dx.doi.org/10.1016/j.canlet.2014.09.005

    CAS  Article  PubMed  Google Scholar 

Download references

Author information

Affiliations

  1. Clinical Laboratory of Taishan Sanatorium of Shandong Province, Tai’an, 271001, China

    Zhong-dong Wang

  2. Interventional Radiology, Yantai Affiliated Hospital of Binzhou Medical University, Yantai, 264100, China

    Fan-yong Qu

  3. Center of Health Examination, Affiliated Hospital of Taishan Medical University, Tai’an, 271001, China

    Yuan-yuan Chen & Zhang-shen Ran

  4. Department of Oncology, Affiliated Hospital of Taishan Medical University, Tai’an, 271001, China

    Hai-yan Liu

  5. Department of Basic Medicine, Taishan Medical University, Tai’an, 271001, China

    Hai-dong Zhang

Authors
  1. Zhong-dong Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Fan-yong Qu
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Yuan-yuan Chen
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Zhang-shen Ran
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Hai-yan Liu
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Hai-dong Zhang
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Zhong-dong Wang.

Additional information

The two authors contributed equally to this work

Project supported by the Science and Technology Project of Higher Education of Shandong Province (No. J12LK07), China

ORCID: Zhong-dong WANG, http://orcid.org/0000-0002-9344-4748

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Wang, Zd., Qu, Fy., Chen, Yy. et al. Involvement of microRNA-718, a new regulator of EGR3, in regulation of malignant phenotype of HCC cells. J. Zhejiang Univ. Sci. B 18, 27–36 (2017). https://doi.org/10.1631/jzus.B1600205

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1631/jzus.B1600205

Key words

  • miR-718
  • MicroRNA
  • Early growth response protein 3 (EGR3)
  • Hepatocellular carcinoma (HCC)
  • Malignant phenotype

关键词

  • miR-718
  • 小非编码RNA
  • 早期生长反应蛋白3
  • 肝癌
  • 表型

CLC number

  • R735.2